HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of complication rates in early-stage breast cancer patients treated with brachytherapy versus whole-breast irradiation.

AbstractBACKGROUND:
The adoption of breast brachytherapy into clinical practice for early-stage breast cancer has increased over the last several years. Studies evaluating complication rates following treatment with brachytherapy have shown conflicting results. We compared local toxicity in patients treated with brachytherapy with those treated with whole-breast irradiation (WBI).
METHODS:
We identified 417 early-stage breast cancer patients treated with breast-conserving surgery and radiation between 2004 and 2010, and compared 271 women treated with intracavitary brachytherapy with 146 women treated with WBI. Long-term complications were assessed using Kaplan-Meier curves with the log-rank test.
RESULTS:
Median follow-up was 4.6 years, and the 5-year incidence of infectious skin complications (9.7 vs. 11.0 %, p = 0.84), abscess (1.1 vs. 0 %, p = 0.15), telangiectasia (8.0 vs. 5.3 %, p = 0.35), and breast pain (14.2 vs. 9.4 %, p = 0.2) was similar between the brachytherapy and WBI cohorts. The brachytherapy cohort had a higher 5-year rate of seroma (46.5 vs. 18.5 %, p < 0.001), and fat necrosis (39.5 vs. 24.4 %, p < 0.001). Brachytherapy patients trended towards more frequent biopsies as a result of fat necrosis to rule out a recurrence (11.2 vs. 6.7 %, p = 0.13).
CONCLUSIONS:
Patients treated with intracavitary brachytherapy had more local toxicity, particularly seroma and fat necrosis. Patients should be counseled on the possible increased rate of long-term complications associated with brachytherapy treatment.
AuthorsNicolas Ajkay, Abigail E Collett, Erica V Bloomquist, Edward J Gracely, Thomas G Frazier, Andrea V Barrio
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 22 Issue 4 Pg. 1140-5 (Apr 2015) ISSN: 1534-4681 [Electronic] United States
PMID25319575 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy (adverse effects)
  • Breast Neoplasms (complications, pathology, radiotherapy)
  • Carcinoma, Ductal, Breast (complications, pathology, radiotherapy)
  • Carcinoma, Intraductal, Noninfiltrating (complications, pathology, radiotherapy)
  • Carcinoma, Lobular (complications, pathology, radiotherapy)
  • Fat Necrosis (etiology)
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prognosis
  • Radiation Injuries (etiology)
  • Retrospective Studies
  • Seroma (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: